Many believe COVID-19 offers the pharmaceutical industry a chance to bolster its public reputation by creating a vaccine that would end the pandemic. A PR makeover always seemed more a hope than a possibility given the low esteem in which people tend to hold drug companies, as well as the general fracturing of American society.
But vaccines are moving forward nonetheless, and with any luck in a few months they could begin to be available outside of clinical trials. That’s when another element of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?